Intraregional variation in treatment of end stage renal failure.

Optimum treatment of end-stage renal failure.

Treatment of end-stage renal failure after heart transplantation.

BACKGROUND Five to 10% of heart-transplant recipients develop end-stage renal failure (ESRF). Little is known about the outcome of these patients under renal replacement therapy. METHODS We conducted a retrospective study in 16 men (mean age 52.8+/-7.4 years at heart transplantation) who developed ESRF 5.3+/-2.1 years later. Results. Haemodialysis (HD) was the first-line treatment (mean Kt/V ...

Acidosis in end-stage renal failure.

K.M.L. Leunissen, MD, PhD, University Hospital Maastricht, Department of Internal Medicine, PO Box 5800, NL-6202 AZ Maastricht (The Netherlands) Acidosis has been identified as one of the uremic toxins. Renal acidosis may contribute to renal osteodystrophy [1] and decreased myocardial contractility [2]. Furthermore, animal experimental studies proved that acidosis plays a pivotal role in the ac...

Prevention of end stage renal failure.

mutual incomprehension is far from inevitable. Indeed, Popper demonstrates that in science competing paradigms may continue side by side for long periods of time, and that new paradigms do not obliterate old ones, but rather incorporate them into more successful models.7 Although the variously constructed models for the health service are political rather than scientific, the principle of adapt...

Lactulose efficacy in reduction of nitrogen products, blood potassium and fluid overload in patients with end-stage renal failure

Chronic kidney disease (CKD) is a major public health problem that often goes unrecognized until late-stagedisease. Patients with chronic kidney disease face with uremic toxins and hyperkalemia. Also fluid overloadin CKD patients is associated with rapid decline in kidney function. Lactulose is a hyper osmotic agent andas a prebiotic plays an important role in regulating serum urea and potassiu...